Description
There is tremendous variation in the plant kingdom, as plants have adapted to many ecological niches with discrete challenges. Part of adaptation is production of novel secondary metabolites, compounds not required for central metabolism that serve a role in the plant, such as defense or attraction of pollinators. The rainforest is replete with unusual plants and their resident metabolites. Indigenous peoples have identified therapeutic qualities of specific plants. How can this knowledge be transferred to aid those suffering beyond the rainforest? Lisa Conte is the CEO, President and Founder of Jaguar Health, a subsidiary of Napo Pharmaceuticals. We discuss process of working with indigenous peoples to learn from their findings, then test and validate them in ways to identify novel mechanisms of action for use in modern medicine.
n this episode, Dr. Kevin Folta speaks with Joe Damond about the rapidly evolving landscape of life sciences, particularly focusing on gene and cell therapies. They discuss the exciting advancements in medical technology, the economic challenges associated with developing new therapies, and the...
Published 11/17/24
In this episode of the Talking Biotech podcast, Kevin Folta interviews Jenny Du, co-founder and senior vice president of operations at Apeel, a company focused on reducing food waste through innovative post-harvest technology. They discuss the significant issue of food waste, particularly in...
Published 11/09/24